Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Worth up to $850 million, the partnership provides “further validation” for Janux at a time of heightened investor scrutiny ...
Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results